MENU
NUVL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nuvalent (NUVL) Ownership - Who owns Nuvalent?
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more
Profile
Industry
N/A
Address
One Broadway
Phone
+1 857 357-7000
Employees
92
Web
https://www.nuvalent.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.34B
P/E Ratio
N/A
Total Cash
1.07B
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash/Share
14.88
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NUVL
Capitalization
5.34B
P/E Ratio
N/A
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash
1.07B
Total Cash/Share
14.88
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.01B
P/B Ratio
5.69
Cash Flow
N/A
Earnings
-4.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
14.48
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-322.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.17
Shares Held By Institutions
7.79B
Shares Outstanding - Current
72.1M
Total Liabilities
94.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-5.327
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NUVL showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Broadway
Phone
+1 857 357-7000
Employees
92
Web
https://www.nuvalent.com